An Israeli biotech company claims that its preliminary mouse research gives her hope of curing cancer "within a year," Newshub reported.
According to the Jerusalem Post, the Israeli society has said it has developed a drug to fight cancer using peptides.
Peptides are chain-linked amino acid compounds that the company uses to target and kill cancer cells in mice.
Dan Aridor, chairman of the board of directors, told Jerusalem Post that the company has a drug hope.
"We believe we will offer complete cancer treatment in a year."
However, the company only tested its mouse drug. It can take up to seven years to get cancer drugs, even with special permission from US regulators, CNBC informs.
The biotech company has not yet published clinical evidence that treatment is effective in humans.
Chief Executive Officer Ilan Morad told Jerusalem Post that she had just completed her first mouse attempt, claiming to be successful.
Before the medicine can get mice to humans, it must undergo strict testing by the Food and Drug Administration.
First laboratory and animal tests must be performed.
If these effects prove to be effective and safe, the drug can be moved into human testing.